What are the treatments for central pontine myelinolysis?

Central pontine myelinolysis is a fatal disease characterized by symmetrical demyelination of the basal part of the pons. It is a rare acute myelinolysis. Hyponatremia is currently thought to be caused by hyponatremia or hyponatremia that corrects too quickly. At this stage, central pontine myelinolysis is still dominated by supportive and symptomatic treatment and active treatment of the underlying disease. Hyponatremia should be corrected slowly without hypertonic saline. Mannitol and furosemide may be used to treat cerebral edema in the acute phase. Early high-dose hormonal shock therapy may inhibit the progression of the disease. Hyperbaric oxygen and plasma exchange may be used.